Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	KPV Lysine-Proline-Valine Sign up to track	VIP Vasoactive Intestinal Peptide Sign up to track
Evidence Grade	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries
Regulatory	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Category	Immune & Inflammatory Modulation	Immune & Inflammatory Modulation
Key Benefits	•Strong anti-inflammatory effects •Gut healing properties •Reduces inflammatory cytokines •May help IBD and IBS +2 more	•Modulates immune system •Reduces inflammation •Treats CIRS and mold illness •Neuroprotective effects +2 more
Dosage	500-1000 mcg mcg	50 mcg mcg
Frequency	1-2x daily	4x daily
Administration	SubcutaneousOral	Intranasal
Mechanism	KPV is a C-terminal tripeptide of α-MSH with potent anti-inflammatory effects. It is being researched for inflammatory bowel disease and various inflammatory conditions.	VIP is a neuropeptide with wide-ranging effects including immune modulation, neuroprotection, and treatment of chronic inflammatory response syndrome (CIRS).
Side Effects / Risks	Not specified	Not specified
Research Status	Research compound	Research compound - used clinically for CIRS